{"DataElement":{"publicId":"6069584","version":"1","preferredName":"Oncotype Recurrence Score Risk Group Category","preferredDefinition":"Text term that represents the risk group for breast cancer as determined by assessment of the Oncotype recurrence score.","longName":"oncotype_risk_group","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"6066847","version":"1","preferredName":"Oncotype DX Breast Cancer Assay Recurrence Score Risk Group","preferredDefinition":"A diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early stage breast cancer. In addition to predicting distant disease recurrence, Oncotype DX also assesses the benefit from certain types of chemotherapy. The assay, performed using formalin-fixed, paraffin-embedded tumor tissue, analyzes the expression of a panel of 21 genes and the results are provided as a Recurrence Score (0-100). The gene panel was selected and the Recurrence Score calculation was derived through extensive laboratory testing and multiple independent clinical development studies. Oncotype DX is validated for use in breast cancer patients whose disease is newly diagnosed, stage I or II, node-negative, estrogen receptor-positive and who will be treated with tamoxifen._Happening again (especially at regular intervals)._A number or range of numeric values measuring performance, function, quality, or ability._The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable._Any number of entities (members) considered as a unit.","longName":"2442625v1.0:6066845v1.0","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"2442625","version":"1","preferredName":"Oncotype DX Breast Cancer Assay","preferredDefinition":"Oncotype DX is a diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early stage breast cancer. In addition to predicting distant disease recurrence, Oncotype DX also assesses the benefit from certain types of chemotherapy. The assay, performed using formalin-fixed, paraffin-embedded tumor tissue, analyzes the expression of a panel of 21 genes and the results are provided as a Recurrence Score (0-100). The gene panel was selected and the Recurrence Score calculation was derived through extensive laboratory testing and multiple independent clinical development studies. Oncotype DX is validated for use in breast cancer patients whose disease is newly diagnosed, stage I or II, node-negative, estrogen receptor-positive and who will be treated with tamoxifen. (from genomichealth.com)","longName":"C52159","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oncotype DX Breast Cancer Assay","conceptCode":"C52159","definition":"A diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early stage breast cancer. In addition to predicting distant disease recurrence, Oncotype DX also assesses the benefit from certain types of chemotherapy. The assay, performed using formalin-fixed, paraffin-embedded tumor tissue, analyzes the expression of a panel of 21 genes and the results are provided as a Recurrence Score (0-100). The gene panel was selected and the Recurrence Score calculation was derived through extensive laboratory testing and multiple independent clinical development studies. Oncotype DX is validated for use in breast cancer patients whose disease is newly diagnosed, stage I or II, node-negative, estrogen receptor-positive and who will be treated with tamoxifen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"09046428-51D4-6C1D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-01-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-01-06","modifiedBy":"ONEDATA","dateModified":"2006-01-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6066845","version":"1","preferredName":"Recurrence Score Risk Group","preferredDefinition":"To come back or to return.:A number or range of numeric values measuring performance, function, quality, or ability.:The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.:Any number of entities (members) considered as a unit.","longName":"C3352:C25338:C17102:C43359","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrence","conceptCode":"C3352","definition":"Happening again (especially at regular intervals).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Risk","conceptCode":"C17102","definition":"The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Group","conceptCode":"C43359","definition":"Any number of entities (members) considered as a unit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65077BFF-B984-58DC-E053-F662850A614C","latestVersionIndicator":"Yes","beginDate":"2018-02-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-12","modifiedBy":"ONEDATA","dateModified":"2018-02-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"65077BFF-B995-58DC-E053-F662850A614C","latestVersionIndicator":"Yes","beginDate":"2018-02-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-12","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeDescription":"Created for Breast CDE spreadsheet. 1.31.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6068755","version":"1","preferredName":"Genomic Test Risk Group Category","preferredDefinition":"A grouping of items based on some commonality or by user defined characteristics.","longName":"6068755v1.0","context":"OCG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"12","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"High","valueDescription":"High risk","ValueMeaning":{"publicId":"2580324","version":"1","preferredName":"High risk","longName":"2580324","preferredDefinition":"The potential future harm that may arise from some present action or attribute or condition is almost certain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Risk","conceptCode":"C102401","definition":"The potential future harm that may arise from some present action or attribute or condition is almost certain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-06D1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-27","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-07-27","modifiedBy":"SHIDED","dateModified":"2013-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"651A3946-C9C4-27BA-E053-F662850ACCEC","beginDate":"2018-02-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-13","modifiedBy":"ONEDATA","dateModified":"2018-02-13","deletedIndicator":"No"},{"value":"Low","valueDescription":"Low risk","ValueMeaning":{"publicId":"2576351","version":"1","preferredName":"Low risk","longName":"2576351","preferredDefinition":"The potential future harm that may arise from some present action or attribute or condition is small.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Risk","conceptCode":"C102403","definition":"The potential future harm that may arise from some present action or attribute or condition is small.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F74C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-29","modifiedBy":"SHIDED","dateModified":"2013-04-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"651A3946-C9E4-27BA-E053-F662850ACCEC","beginDate":"2018-02-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-13","modifiedBy":"ONEDATA","dateModified":"2018-02-13","deletedIndicator":"No"},{"value":"Intermediate","valueDescription":"Intermediate Risk","ValueMeaning":{"publicId":"4903637","version":"1","preferredName":"Intermediate Risk","longName":"4903637","preferredDefinition":"The potential future harm that may arise from some present action or attribute or condition is moderate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intermediate Risk","conceptCode":"C102402","definition":"The potential future harm that may arise from some present action or attribute or condition is moderate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B153AB5-0BD7-4322-E050-BB89AD433CC8","latestVersionIndicator":"Yes","beginDate":"2015-07-17","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-07-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"653211AF-6B2C-6917-E053-F662850A3254","beginDate":"2018-02-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-14","modifiedBy":"ONEDATA","dateModified":"2018-02-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433877","version":"1","preferredName":"Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4D2F-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-28","modifiedBy":"ONEDATA","dateModified":"2005-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"651A3946-C9A2-27BA-E053-F662850ACCEC","latestVersionIndicator":"Yes","beginDate":"2018-02-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-13","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeDescription":"Created for Breast CDE spreadsheet. 1.31.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000009","version":"1","longName":"Breast","context":"OCG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"What is the patient's risk gr","type":"Preferred Question Text","description":"What is the patient's risk group according to the Oncotype recurrence score?","url":null,"context":"OCG"}],"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"651B2210-0FA1-2783-E053-F662850AF103","latestVersionIndicator":"Yes","beginDate":"2018-02-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-13","modifiedBy":"COOPERM","dateModified":"2018-03-05","changeDescription":"Created for Breast CDE spreadsheet. 1.31.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}